Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17320278rdf:typepubmed:Citationlld:pubmed
pubmed-article:17320278lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:17320278lifeskim:mentionsumls-concept:C0035647lld:lifeskim
pubmed-article:17320278lifeskim:mentionsumls-concept:C0346647lld:lifeskim
pubmed-article:17320278lifeskim:mentionsumls-concept:C0021083lld:lifeskim
pubmed-article:17320278lifeskim:mentionsumls-concept:C0003320lld:lifeskim
pubmed-article:17320278lifeskim:mentionsumls-concept:C1521840lld:lifeskim
pubmed-article:17320278pubmed:issue2lld:pubmed
pubmed-article:17320278pubmed:dateCreated2007-5-30lld:pubmed
pubmed-article:17320278pubmed:abstractTextTo be effective and selective, immunotherapy ideally targets specifically tumor cells and spares normal tissues. Identification of tumor specific antigens is a prerequisite to establish an effective immunotherapy. Still very little is known about the expression of tumor-related antigens in pancreatic neoplasms. Cancer Testis antigens (CT) are antigens shared by a variety of malignant tumors, but not by normal tissues with the exception of germ cells in testis. Restricted expression in neoplastic tissues and inherent immunogenic features make CT antigens ideal for use in immunotherapy. We analyzed the expression of a selected panel of nine CT antigens that have been proven to elicit an efficient immunogenic response in other malignancies. In addition we analyzed the expression of HERV-K-MEL, an immunogenic antigen of viral origin.lld:pubmed
pubmed-article:17320278pubmed:languageenglld:pubmed
pubmed-article:17320278pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17320278pubmed:citationSubsetIMlld:pubmed
pubmed-article:17320278pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17320278pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17320278pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17320278pubmed:statusMEDLINElld:pubmed
pubmed-article:17320278pubmed:monthJullld:pubmed
pubmed-article:17320278pubmed:issn0304-3835lld:pubmed
pubmed-article:17320278pubmed:authorpubmed-author:RomeroPPlld:pubmed
pubmed-article:17320278pubmed:authorpubmed-author:KochMMlld:pubmed
pubmed-article:17320278pubmed:authorpubmed-author:WeitzJJlld:pubmed
pubmed-article:17320278pubmed:authorpubmed-author:KrempienRRlld:pubmed
pubmed-article:17320278pubmed:authorpubmed-author:RimoldiDDlld:pubmed
pubmed-article:17320278pubmed:authorpubmed-author:Z'graggenKKlld:pubmed
pubmed-article:17320278pubmed:authorpubmed-author:DingX FXFlld:pubmed
pubmed-article:17320278pubmed:authorpubmed-author:BeckhovePPlld:pubmed
pubmed-article:17320278pubmed:authorpubmed-author:BuchlerM WMWlld:pubmed
pubmed-article:17320278pubmed:authorpubmed-author:NiethammerA...lld:pubmed
pubmed-article:17320278pubmed:authorpubmed-author:Schmitz-Winne...lld:pubmed
pubmed-article:17320278pubmed:authorpubmed-author:Galindo-Escob...lld:pubmed
pubmed-article:17320278pubmed:issnTypePrintlld:pubmed
pubmed-article:17320278pubmed:day18lld:pubmed
pubmed-article:17320278pubmed:volume252lld:pubmed
pubmed-article:17320278pubmed:ownerNLMlld:pubmed
pubmed-article:17320278pubmed:authorsCompleteYlld:pubmed
pubmed-article:17320278pubmed:pagination290-8lld:pubmed
pubmed-article:17320278pubmed:meshHeadingpubmed-meshheading:17320278...lld:pubmed
pubmed-article:17320278pubmed:meshHeadingpubmed-meshheading:17320278...lld:pubmed
pubmed-article:17320278pubmed:meshHeadingpubmed-meshheading:17320278...lld:pubmed
pubmed-article:17320278pubmed:meshHeadingpubmed-meshheading:17320278...lld:pubmed
pubmed-article:17320278pubmed:meshHeadingpubmed-meshheading:17320278...lld:pubmed
pubmed-article:17320278pubmed:meshHeadingpubmed-meshheading:17320278...lld:pubmed
pubmed-article:17320278pubmed:meshHeadingpubmed-meshheading:17320278...lld:pubmed
pubmed-article:17320278pubmed:meshHeadingpubmed-meshheading:17320278...lld:pubmed
pubmed-article:17320278pubmed:year2007lld:pubmed
pubmed-article:17320278pubmed:articleTitlePotential target antigens for immunotherapy in human pancreatic cancer.lld:pubmed
pubmed-article:17320278pubmed:affiliationDepartment of General Surgery, University Hospital of Heidelberg, Germany.lld:pubmed
pubmed-article:17320278pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17320278lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17320278lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17320278lld:pubmed